Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001943192-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | May 7, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
19,491
Total Value
$115,368.15
P&L
+inf% (+$468,435.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | May 4, 2026 | Exercise/Conversion | 4,250 | $0.00 | $0.00 | 121,149 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | May 5, 2026 | Sale | 2,181 | $46.65 | $101,743.65 | 118,968 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | May 6, 2026 | Sale | 310 | $43.95 | $13,624.50 | 118,658 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Performance-based restricted stock units | Derivative | May 4, 2026 | Grant/Award | 8,500 | $0.00 | $0.00 | 8,500 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Performance-based restricted stock units | Derivative | May 4, 2026 | Exercise/Conversion | 4,250 | $0.00 | $0.00 | 4,250 | Direct | โ | View Details |